Castle Biosciences, Inc. (CSTL)

USD 26.52

(-5.76%)

Operating Expenses Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual operating expenses in 2023 was 242.78 Million USD , up 18.37% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly operating expenses in 2024 Q2 was 64.76 Million USD , up 4.68% from previous quarter.
  • Castle Biosciences, Inc. reported a annual operating expenses of 196.17 Million USD in annual operating expenses 2022, up 65.77% from previous year.
  • Castle Biosciences, Inc. reported a annual operating expenses of 118.34 Million USD in annual operating expenses 2021, up 98.87% from previous year.
  • Castle Biosciences, Inc. reported a quarterly operating expenses of 64.76 Million USD for 2024 Q2, up 4.68% from previous quarter.
  • Castle Biosciences, Inc. reported a quarterly operating expenses of 61.86 Million USD for 2024 Q1, up 9.14% from previous quarter.

Annual Operating Expenses Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Operating Expenses of Castle Biosciences, Inc. (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 242.78 Million USD 18.37%
2022 196.17 Million USD 65.77%
2021 118.34 Million USD 98.87%
2020 59.5 Million USD 59.85%
2019 37.22 Million USD 74.57%
2018 21.32 Million USD 8.07%
2017 19.73 Million USD 0.0%

Peer Operating Expenses Comparison of Castle Biosciences, Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD -62.949%
Prenetics Global Limited 60.73 Million USD -299.731%
Star Equity Holdings, Inc. 16.27 Million USD -1392.029%
CareDx, Inc 277.76 Million USD 12.595%
Exact Sciences Corporation 2.06 Billion USD 88.217%
Exagen Inc. 52.29 Million USD -364.274%
Inotiv, Inc. 246.9 Million USD 1.669%
Guardant Health, Inc. 901.62 Million USD 73.073%
Biodesix, Inc. 77.41 Million USD -213.596%
BioNexus Gene Lab Corp. 3.92 Million USD -6088.572%
Precipio, Inc. 13.63 Million USD -1680.195%
iSpecimen Inc. 16.27 Million USD -1391.547%
Natera, Inc. 938.98 Million USD 74.144%
Aspira Women's Health Inc. 24.11 Million USD -906.813%
Standard BioTools Inc. 113.48 Million USD -113.926%
23andMe Holding Co. 420.73 Million USD 42.295%
Personalis, Inc. 128.14 Million USD -89.461%
Aclaris Therapeutics, Inc. 110.52 Million USD -119.663%
Applied DNA Sciences, Inc. 16.48 Million USD -1372.597%
OpGen, Inc. 30.65 Million USD -691.909%
T2 Biosystems, Inc. 41.49 Million USD -485.104%
Myriad Genetics, Inc. 600.1 Million USD 59.543%
ICON Public Limited Company 755.64 Million USD 67.871%
NeoGenomics, Inc. 341.25 Million USD 28.855%
Star Equity Holdings, Inc. 16.27 Million USD -1392.029%
IDEXX Laboratories, Inc. 1.09 Billion USD 77.784%
RadNet, Inc. 268.87 Million USD 9.705%
MDxHealth SA 71.25 Million USD -240.719%
Psychemedics Corporation 11.33 Million USD -2042.077%
Illumina, Inc. 3.81 Billion USD 93.633%
Check-Cap Ltd. 19.28 Million USD -1158.791%
Twist Bioscience Corporation 354.18 Million USD 31.452%
DarioHealth Corp. 62.17 Million USD -290.496%
Fulgent Genetics, Inc. 171.9 Million USD -41.23%
Sera Prognostics, Inc. 39.91 Million USD -508.22%
ENDRA Life Sciences Inc. 10.52 Million USD -2207.662%
OPKO Health, Inc. 574.68 Million USD 57.754%
Medpace Holdings, Inc. 187.68 Million USD -29.36%
Neogen Corporation 405.23 Million USD 40.089%
Intelligent Bio Solutions Inc. 11.7 Million USD -1973.509%
Prenetics Global Limited 60.73 Million USD -299.731%
Mainz Biomed B.V. 27.15 Million USD -794.085%
bioAffinity Technologies, Inc. 8.76 Million USD -2669.964%
Trinity Biotech plc 46.49 Million USD -422.17%
Neuronetics, Inc. 82.25 Million USD -195.145%
Sotera Health Company 300.46 Million USD 19.198%
bioAffinity Technologies, Inc. 8.76 Million USD -2669.964%